ChemoCentryx (CCXI) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Join SI Premium – FREE
ChemoCentryx (NASDAQ: CCXI) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
- Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
